These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes. Vehkala L; Ukkola O; Kesäniemi YA; Kähönen M; Nieminen MS; Salomaa V; Jula A; Hörkkö S Ann Med; 2013 Dec; 45(8):501-10. PubMed ID: 24131174 [TBL] [Abstract][Full Text] [Related]
11. Epitope characterization of malondialdehyde-acetaldehyde adducts using an enzyme-linked immunosorbent assay. Xu D; Thiele GM; Kearley ML; Haugen MD; Klassen LW; Sorrell MF; Tuma DJ Chem Res Toxicol; 1997 Sep; 10(9):978-86. PubMed ID: 9305579 [TBL] [Abstract][Full Text] [Related]
12. T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated. Willis MS; Thiele GM; Tuma DJ; Klassen LW Int Immunopharmacol; 2003 Oct; 3(10-11):1381-99. PubMed ID: 12946435 [TBL] [Abstract][Full Text] [Related]
13. Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts. Kummu O; Turunen SP; Prus P; Lehtimäki J; Veneskoski M; Wang C; Hörkkö S Immunology; 2014 Mar; 141(3):416-30. PubMed ID: 24168430 [TBL] [Abstract][Full Text] [Related]
14. Malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis and other rheumatic conditions. Mikuls TR; Duryee MJ; England BR; Anderson DR; Hearth-Holmes M; Su K; Michaud K; Payne JB; Sayles H; Hunter C; McGowan JD; Klassen LW; Thiele GM Int Immunopharmacol; 2018 Mar; 56():113-118. PubMed ID: 29414640 [TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to Malondialdehyde-Acetaldehyde Are Detected Prior to Rheumatoid Arthritis Diagnosis and After Other Disease Specific Autoantibodies. Mikuls TR; Edison J; Meeshaw E; Sayles H; England BR; Duryee MJ; Hunter CD; Kelmenson LB; Kay Moss L; Feser ML; Wagner B; Parish MC; Deane KD; Thiele GM Arthritis Rheumatol; 2020 Dec; 72(12):2025-2029. PubMed ID: 32621635 [TBL] [Abstract][Full Text] [Related]
16. Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint. Mikuls TR; Duryee MJ; Rahman R; Anderson DR; Sayles HR; Hollins A; Michaud K; Wolfe F; Thiele GE; Sokolove J; Robinson WH; Lingampalli N; Nicholas AP; Talmon GA; Su K; Zimmerman MC; Klassen LW; Thiele GM Rheumatology (Oxford); 2017 Oct; 56(10):1794-1803. PubMed ID: 28957552 [TBL] [Abstract][Full Text] [Related]
17. Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury. Hill GE; Miller JA; Baxter BT; Klassen LW; Duryee MJ; Tuma DJ; Thiele GM Atherosclerosis; 1998 Nov; 141(1):107-16. PubMed ID: 9863543 [TBL] [Abstract][Full Text] [Related]
18. Malondialdehyde-Acetaldehyde Modified (MAA) Proteins Differentially Effect the Inflammatory Response in Macrophage, Endothelial Cells and Animal Models of Cardiovascular Disease. Duryee MJ; Clemens DL; Opperman PJ; Thiele GM; Duryee LM; Garvin RP; Anderson DR Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884754 [TBL] [Abstract][Full Text] [Related]
19. Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts. Thiele GM; Duryee MJ; Hunter CD; England BR; Fletcher BS; Daubach EC; Pospisil TP; Klassen LW; Mikuls TR Int Immunopharmacol; 2020 Jun; 83():106433. PubMed ID: 32224441 [TBL] [Abstract][Full Text] [Related]
20. IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope. Que X; Widhopf GF; Amir S; Hartvigsen K; Hansen LF; Woelkers D; Tsimikas S; Binder CJ; Kipps TJ; Witztum JL PLoS One; 2013; 8(6):e65203. PubMed ID: 23840319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]